Press Releases
-
May 06, 2024
Omnicell Supports Global Charity Mercy Ships with Pharmacy Technology Donation
Omnicell, Inc. (Nasdaq:OMCL) (“Omnicell” or the “Company”), a leader in transforming the pharmacy care delivery model, today announced continued support for the global charity Mercy Ships with the donation of solutions from the recently announced XT...
-
May 03, 2024
Omnicell to Present at the BofA Securities 2024 Health Care Conference
Omnicell, Inc. (Nasdaq:OMCL), a leader in transforming the pharmacy care delivery model, will present at the BofA Securities 2024 Health Care Conference in Las Vegs, NV, on Wednesday, May 15, 2024 at 3:40 p.m. PT. Live and archived webcasts of the...
-
May 03, 2024
Omnicell to Present at the BofA Securities 2024 Health Care Conference
Omnicell, Inc. (Nasdaq:OMCL), a leader in transforming the pharmacy care delivery model, will present at the BofA Securities 2024 Health Care Conference in Las Vegs, NV, on Wednesday, May 15, 2024 at 3:40 p.m. PT. Live and archived webcasts of the...
-
May 02, 2024
Omnicell Announces First Quarter 2024 Results
Results exceed prior first quarter guidance across all metrics Total GAAP revenues of $246 million Omnicell, Inc. (NASDAQ:OMCL) (“Omnicell,” “we,” “our,” “us,” “management,” or the “Company”), a leader in transforming the pharmacy care delivery...
-
May 02, 2024
Omnicell Announces First Quarter 2024 Results
Results exceed prior first quarter guidance across all metrics Total GAAP revenues of $246 million Omnicell, Inc. (NASDAQ:OMCL) (“Omnicell,” “we,” “our,” “us,” “management,” or the “Company”), a leader in transforming the pharmacy care delivery...
-
April 16, 2024
Omnicell Announces XT Amplify
Multi-year Innovation Program Designed to Maximize Value and Outcomes for XT Automated Dispensing System Omnicell, Inc. (Nasdaq:OMCL) (“Omnicell” or the “Company”), a leader in transforming the pharmacy care delivery model, today announced XT...
-
April 08, 2024
Omnicell to Release First Quarter 2024 Financial Results on May 2, 2024
Omnicell, Inc. (Nasdaq:OMCL), a leader in transforming the pharmacy care delivery model, will release its financial results for the first quarter 2024, before market open on Thursday, May 2, 2024. The Company will host a conference call and webcast...
-
April 08, 2024
Omnicell to Release First Quarter 2024 Financial Results on May 2, 2024
Omnicell, Inc. (Nasdaq:OMCL), a leader in transforming the pharmacy care delivery model, will release its financial results for the first quarter 2024, before market open on Thursday, May 2, 2024. The Company will host a conference call and webcast...
-
March 11, 2024
Omnicell to Present at the virtual KeyBanc Annual Life Sciences & MedTech Investor Forum
Omnicell, Inc. (Nasdaq:OMCL), a leader in transforming the pharmacy care delivery model, will present at the virtual KeyBanc Annual Life Sciences & MedTech Investor Forum on Wednesday, March 20, 2024 at 4:30 p.m. ET. Live and archived webcasts of...
-
March 11, 2024
Omnicell to Present at the virtual KeyBanc Annual Life Sciences & MedTech Investor Forum
Omnicell, Inc. (Nasdaq:OMCL), a leader in transforming the pharmacy care delivery model, will present at the virtual KeyBanc Annual Life Sciences & MedTech Investor Forum on Wednesday, March 20, 2024 at 4:30 p.m. ET. Live and archived webcasts of...
-
March 11, 2024
Omnicell to Present at the virtual KeyBanc Annual Life Sciences & MedTech Investor Forum
Omnicell, Inc. (Nasdaq:OMCL), a leader in transforming the pharmacy care delivery model, will present at the virtual KeyBanc Annual Life Sciences & MedTech Investor Forum on Wednesday, March 20, 2024 at 4:30 p.m. ET. Live and archived webcasts of...
-
February 08, 2024
Omnicell Announces Fiscal Year and Fourth Quarter 2023 Results
Full Year 2023 GAAP Revenues of $1.147 billion Full Year 2023 GAAP net loss of $20 million and GAAP net loss per diluted share of $0.45 Full Year 2023 Non-GAAP EBITDA of $138 million and Non-GAAP net income per diluted share of $1.91 Full Year 2023...
-
February 08, 2024
Omnicell Announces Fiscal Year and Fourth Quarter 2023 Results
Full Year 2023 GAAP Revenues of $1.147 billion Full Year 2023 GAAP net loss of $20 million and GAAP net loss per diluted share of $0.45 Full Year 2023 Non-GAAP EBITDA of $138 million and Non-GAAP net income per diluted share of $1.91 Full Year 2023...
-
January 16, 2024
Omnicell to Release Fourth Quarter and Full Year 2023 Financial Results on February 8, 2024
Omnicell, Inc. (Nasdaq:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, will release its financial results for the fourth quarter and full year 2023, before market open on...
-
January 11, 2024
Omnicell Elects Eileen Voynick to Board of Directors
Sales and Operational Veteran Brings Additional Global Business Experience and Healthcare Technology Expertise to Board Omnicell, Inc. (Nasdaq: OMCL) (“Omnicell” or the “Company”), a leader in transforming the pharmacy care delivery model, today...
-
December 03, 2023
Omnicell Showcases Outcomes-Centric Innovation at ASHP Midyear 2023
Robotics, Smart Devices, Software, and Expert Services Designed to Drive Enhanced Outcomes for Healthcare Providers Across the Care Continuum.